Clinical Guidelines & Documents

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application. 

The Society approved the scope for the following new documents and a focused update that are currently under development: 

  1. 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathies
  2. 2019 HRS Expert Consensus Statement on Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders 
  3. 2019 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias
  4. 2019  HRS/EHRA/APHRS/LAHRS Focused Update to 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter Defibrillator Programming and Testing (Appendix B)
  5. 2020 HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy
HRS is partnering with Guideline Central to create pocket cards at a discount to HRS members. Visit www.guidelinecentral.com  to learn more about HRS titles in circulation and how you can access this content in print and on your mobile device.
 

Please email clinicaldocs@hrsonline.org  should you have questions or need further information.

License clinical documents: Complete our license form and submit to Tonia Jones at tjones@hrsonline.org if you are interested in licensing our clinical document content (e.g., clinician summary, slide sets, etc.).

Volunteer with clinical documents: Contact us at clinicaldocs@hrsonline.org  if you are interested in serving as a peer reviewer or writing group member for future clinical documents. Please include your areas of expertise and CV.

Featured Clinical Documents

36022 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January 28, 2019—The purpose of this document is to update the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2014 AF Guideline) in areas for which new evidence has emerged since its publication. The scope of this focused update of the 2014 AF Guideline includes revisions to the section on anticoagulant (because of the approval of new medications and thromboembolism protection devices), revisions to the section on catheter ablation of atrial fibrillation (AF), revisions to the section on the management of AF complicating acute coronary syndrome (ACS), and new sections on device detection of AF and weight loss. The areas of the 2014 AF Guideline that were updated were limited to those for which important new data from clinical trials had emerged and/or new U.S. Food and Drug Administration (FDA) indications for thromboembolism protection devices have appeared in the data available to the writing group up to August 2018.

Download the PDF 718.92 kB

30993 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

October 30, 2017—The 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, accompanied by the Executive Summary and the Systematic Review, is intended to guide management of adults who have ventricular arrhythmias or who are at risk for sudden cardiac death (SCD), including diseases and syndromes associated with a risk of SCD from ventricular arrhythmias. 

Download the PDF 8.67 MB